(redirected from Sifrol)
Also found in: Medical.
Related to Sifrol: pramipexole, Madopar


A dopamine agonist used in the treatment of Parkinson's disease.

[pr(opyl) + ami(no) + pex-, of unknown meaning + (thiaz)ole.]


n pramipexol m
References in periodicals archive ?
188 BRIEF HISTORY 188 PRODUCTS 188 Mirapexin 188 Sifrol 189 Pexola 189 Mirapex 189 BRAEBON MEDICAL 189 BRIEF HISTORY 189 SELECTED SLEEP PRODUCTS 190 PureFlow Oronasal Cannula & Filter Model 0597 190 PureFlow Duo Oronasal Cannula & Filter Model 0588 190 Nasal & Oral Luer Lock Cannula & Safety Filter Model 0589 190 Large Bore Nasal & Oral Cannula & Filter Model 0587 190 Adjustable and Nasal Luer Lock Cannula & Filter Model 0599 190 ValueFlow Nasal Cannula With Male Luer Lock Model 5582 191 Large Bore Nasal Cannula & Safety Filter Model 0582 191 Model 0582M CO2 191 Model 0582 CO2 191 PureFlow 191 Disposable Airflow 191 MediByte 191 MediByte Junior 192 DentiTrac 192 CADWELL LABORATORIES INC.
The market is dominated by branded products such as Boehringer Ingelheim's Mirapex/Mirapexin / Sifrol / Mirapex ER / Mirapexin ER (pramipexole), GlaxoSmithKline's (GSK) Requip/Requip XL (ropinirole), Orion / Novartis' Stalevo/Comtan (carbidopa/levodopa/entacapone) and Teva/Lundbeck's Azilect/Agilect (rasagiline).
Find out how the drugs Stalevo/Comtess, Sifrol, Azilect and Requip can perform to 2021, seeing potential revenues.
The findings also reveal that although interviewed experts have similar views of immediate-release and extended-release pramipexole (Boehringer Ingelheim's Mirapex/Mirapexin/Sifrol/BI-Sifrol, generics; Mirapex ER/Mirapexin ER, Sifrol Retard) and immediate-release and controlled-release ropinirole (GlaxoSmithKline's Requip, generics; GlaxoSmithKline/SkyePharma's Requip XL/LP/RP/Modutab/Prolib), a higher percentage of surveyedneurologists chose pramipexole (26 percent) over ropinirole (18 percent) as the most effective agent for the treatment of advanced Parkinson's disease.